[1]
Bacinschi, N. et al. 2026. Use of glucocorticoids in SARS CoV 2 infection: pros and cons. Public Health Economy and Management in Medicine. 1(88) (Jun. 2026), 4–20. DOI:https://doi.org/10.52556/2587-3873.2021.1(88).01.